Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
14 /100
LOW RISK
Score updated Oct 27, 2026

AXSM — Axsome Therapeutics, Inc. Dilution Risk Tracker

Track AXSM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AXSM — Get alerts when the score changes →

As of October 27, 2026, Axsome Therapeutics, Inc. (AXSM) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. Axsome Therapeutics, Inc. has a market capitalization of $7.51B, 52.38M shares outstanding, 418 institutional holders tracked. Stored dilution-related fields include 28.4K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AXSM.
🔔 Track AXSM — Get forecast alerts →

Market Data

Market Cap$7.51B
Shares Outstanding52.38M
Float43.55M
Cash$319.85M
Debt$187.96M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore14/100DilutionWatch score record
Shares Outstanding52.38MVerified float table or market cache
Public Float43.55MVerified float table or market cache
Market Cap$7.51BMarket data cache
Cash Runway31.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants28.4KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

AXSM SEC Filing Activity — Last 12 Months

Shares outstanding reported by AXSM on the cover page of its latest 10-K/10-Q: 52.38M as of August 03, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for AXSM in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)13Aug 10, 2026
10-Qquarterly report2Aug 10, 2026
DEF 14Aproxy statement1Apr 24, 2026
3initial insider ownership1Mar 26, 2026
5annual insider ownership38Sep 03, 2026

Institutional Holdings

QoQ: ↑ 10.9% shares (2026Q1 vs prior)
418 institutional holders · 44.34M shares
#1 BlackRock, Inc. 3.91M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 3.88M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 2.06M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.11M
Days to Cover3.3
% of Float7.2%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-10
xbrl XBRL CONVERTIBLE 2019-03-15
4 INSIDER TRANSACTION 2026-04-23
4 INSIDER TRANSACTION 2026-04-23
4 INSIDER TRANSACTION 2026-04-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AXSM Dilution Snapshot

Axsome Therapeutics, Inc. (AXSM) has a DilutionScore of 14/100, rated Low dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AXSM's DilutionScore has held steady at 14/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 30 – Oct 27, 202614/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

AXSM shares outstanding have decreased 0.0% from 51.46M (May 2026) to 51.46M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 07, 202651.46M43.54M▲ 0.08%
May 06, 202651.46M43.51M▲ 0.62%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track AXSM Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment AXSM files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking AXSM — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AXSM
AXSM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.